Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_assertion description "[Immediate early lowering of intracellular pH with lonidamine or lactate at extracellular pH 6.5 correlated positively with diminished cell viability within 48 h. These findings indicate that MCT1 is a potential therapeutic target and that neuroblastoma therapy may be enhanced by therapeutic strategies to inhibit or overwhelm MCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_assertion evidence source_evidence_literature NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_assertion SIO_000772 17000864 NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_assertion wasDerivedFrom befree-20150227 NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_assertion wasGeneratedBy ECO_0000203 NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP890011.RAHH6l2zFTaWfUMIaX_F2QFlRfbGMwcDaVAX2LBBe9gZ0130_provenance.